Alemtuzumab.

Published

Journal Article

Alemtuzumab is a humanized CD52-specific monoclonal antibody that is increasingly used off-label as an induction agent in solid organ transplantation, particularly in the setting of maintenance immunosuppression minimization protocols. In this review, we briefly discuss this agent's mechanisms of action and summarize evidence supporting its use in this clinical setting.

Full Text

Duke Authors

Cited Authors

  • Weaver, TA; Kirk, AD

Published Date

  • December 27, 2007

Published In

Volume / Issue

  • 84 / 12

Start / End Page

  • 1545 - 1547

PubMed ID

  • 18165760

Pubmed Central ID

  • 18165760

International Standard Serial Number (ISSN)

  • 0041-1337

Digital Object Identifier (DOI)

  • 10.1097/01.tp.0000296680.75175.67

Language

  • eng

Conference Location

  • United States